/Companies

Sensorion

9 known investors

Find your way into Sensorion

Sign up to see every warm intro you have to Sensorion

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensorion team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.

Investors · 9

Also in the syndicate · 5

Aquilo CapitalArtalCoastlands CapitalCormorant Asset ManagementSphera Healthcare

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Sensorion do?
Sensorion is a French clinical-stage biopharmaceutical company founded in 2009 in Montpellier that develops gene-therapy and small-molecule treatments for inner-ear disorders like genetic deafness and tinnitus.
Who are Sensorion's investors?
Sensorion's investors include Sofinnova Partners, Invus, REDMILE, Sanofi Ventures.